{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:09:57Z","timestamp":1789427397071,"version":"build-2803163510"},"reference-count":47,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T00:00:00Z","timestamp":1672358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012283","name":"Chiayi Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CORPG6K0071"],"award-info":[{"award-number":["CORPG6K0071"]}],"id":[{"id":"10.13039\/501100012283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Co-infection of Helicobacter pylori and Fusobacterium nucleatum is a microbial biomarker for poor prognosis of gastric cancer patients. Fusobacterium nucleatum is associated with microsatellite instability and the accumulation of mutations in colorectal cancer. Here, we investigated the mutation landscape of Fusobacterium nucleatum-positive resected gastric cancer tissues using Illumina TruSight Oncology 500 comprehensive panel. Sequencing data were processed to identify the small nucleotide variants, small insertions and deletions, and unstable microsatellite sites. The bioinformatic algorithm also calculated copy number gains of preselected genes and tumor mutation burden. The recurrent genetic aberrations were identified in this study cohort. For gene amplification events, ERBB2, cell cycle regulators, and specific FGF ligands and receptors were the most frequently amplified genes. Pathogenic activation mutations of ERBB2, ERBB3, and PIK3CA, as well as loss-of-function of TP53, were identified in multiple patients. Furthermore, Fusobacterium nucleatum infection is positively correlated with a higher tumor mutation burden. Survival analysis showed that the combination of Fusobacterium nucleatum infection and high tumor mutation burden formed an extremely effective biomarker to predict poor prognosis. Our results indicated that the ERBB2-PIK3-AKT-mTOR pathway is frequently activated in gastric cancer and that Fusobacterium nucleatum and high mutation burden are strong biomarkers of poor prognosis for gastric cancer patients.<\/jats:p>","DOI":"10.3390\/cancers15010269","type":"journal-article","created":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T03:00:59Z","timestamp":1672628459000},"page":"269","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-5204","authenticated-orcid":false,"given":"Yung-Yu","family":"Hsieh","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan"},{"name":"College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Lin","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, National Chung Cheng University, Chiayi 621301, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, National Chung Cheng University, Chiayi 621301, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shui-Yi","family":"Tung","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi 613016, Taiwan"},{"name":"College of Medicine, Chang Gung University, Taoyuan 333323, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5457-9623","authenticated-orcid":false,"given":"Chin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, National Chung Cheng University, Chiayi 621301, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","article-title":"Microbiota and gastric cancer","volume":"86","author":"Bessede","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Wen, J., Lau, H.C., Peppelenbosch, M., and Yu, J. (2021). Gastric Microbiota beyond H. pylori: An Emerging Critical Character in Gastric Carcinogenesis. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111680"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e12786","DOI":"10.1111\/hel.12786","article-title":"Helicobacter pylori infection is associated with the co-occurrence of bacteria in the oral cavity and the gastric mucosa","volume":"26","author":"Wu","year":"2021","journal-title":"Helicobacter"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1158\/1055-9965.EPI-19-0355","article-title":"The Epidemiology of Gastric Cancers in the Era of Helicobacter pylori Eradication: A Nationwide Cancer Registry-Based Study in TaiwanEpidemiology of Gastric Cancer in Taiwan","volume":"28","author":"Chang","year":"2019","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.tim.2020.02.004","article-title":"The Helicobacter pylori Cag type IV secretion system","volume":"28","author":"Cover","year":"2020","journal-title":"Trends Microbiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41423-019-0339-5","article-title":"Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis","volume":"17","author":"Knight","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Fischer, W., and Haas, R. (2020). Different roles of integrin-beta1 and integrin-alphav for type IV secretion of CagA versus cell elongation phenotype and cell lifting by Helicobacter pylori. PLoS Pathog., 16.","DOI":"10.1371\/journal.ppat.1008564"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1053\/j.gastro.2018.08.041","article-title":"Loss of tight junction protein claudin 18 promotes progressive neoplasia development in mouse stomach","volume":"155","author":"Hagen","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e12583","DOI":"10.1111\/hel.12583","article-title":"Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection","volume":"24","author":"Uotani","year":"2019","journal-title":"Helicobacter"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e00790-19","DOI":"10.1128\/IAI.00790-19","article-title":"Bacterial energetic requirements for Helicobacter pylori Cag type IV secretion system-dependent alterations in gastric epithelial cells","volume":"88","author":"Lin","year":"2020","journal-title":"Infect. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Stein, S.C., Faber, E., Bats, S.H., Murillo, T., Speidel, Y., Coombs, N., and Josenhans, C. (2017). Helicobacter pylori modulates host cell responses by CagT4SS-dependent translocation of an intermediate metabolite of LPS inner core heptose biosynthesis. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006514"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13099-020-00368-3","article-title":"CagA orchestrates eEF1A1 and PKC\u03b4 to induce interleukin-6 expression in Helicobacter pylori-infected gastric epithelial cells","volume":"12","author":"Xu","year":"2020","journal-title":"Gut Pathog."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/2211-5463.13390","article-title":"Helicobacter pylori infection affects the human gastric microbiome, as revealed by metagenomic sequencing","volume":"12","author":"Wang","year":"2022","journal-title":"FEBS Open Bio"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13073-018-0586-6","article-title":"Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers","volume":"10","author":"Hale","year":"2018","journal-title":"Genome Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1136\/gutjnl-2015-310101","article-title":"Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis","volume":"65","author":"Mima","year":"2016","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3748\/wjg.v22.i2.557","article-title":"Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer","volume":"22","author":"Nosho","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.chom.2016.07.006","article-title":"Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma enrichment by binding to tumor-expressed Gal-GalNAc","volume":"20","author":"Abed","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13073-016-0290-3","article-title":"Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions","volume":"8","author":"Baxter","year":"2016","journal-title":"Genome Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1136\/gutjnl-2016-312766","article-title":"Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia","volume":"66","author":"Wong","year":"2017","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Basic, A., Blomqvist, M., Dahlen, G., and Svensater, G. (2017). The proteins of Fusobacterium spp. involved in hydrogen sulfide production from L-cysteine. BMC Microbiol., 17.","DOI":"10.1186\/s12866-017-0967-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1099\/mic.0.039180-0","article-title":"Production of hydrogen sulfide by two enzymes associated with biosynthesis of homocysteine and lanthionine in Fusobacterium nucleatum subsp. nucleatum ATCC 25586","volume":"156","author":"Yoshida","year":"2010","journal-title":"Microbiology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1158\/1541-7786.MCR-06-0439","article-title":"Hydrogen sulfide induces direct radical-associated DNA damage","volume":"5","author":"Wagner","year":"2007","journal-title":"Mol. Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/tx300066z","article-title":"Generation of DNA-damaging reactive oxygen species via the autoxidation of hydrogen sulfide under physiologically relevant conditions: Chemistry relevant to both the genotoxic and cell signaling properties of H(2)S","volume":"25","author":"Hoffman","year":"2012","journal-title":"Chem. Res. Toxicol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13099-020-00384-3","article-title":"Fusobacterium nucleatum infection correlates with two types of microsatellite alterations in colorectal cancer and triggers DNA damage","volume":"12","author":"Okita","year":"2020","journal-title":"Gut Pathog."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41598-017-18596-0","article-title":"Increased abundance of Clostridium and Fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan","volume":"8","author":"Hsieh","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7311","DOI":"10.3748\/wjg.v27.i42.7311","article-title":"Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients","volume":"27","author":"Hsieh","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e001904","DOI":"10.1136\/jitc-2020-001904","article-title":"Tumor mutational burden assessment in non-small-cell lung cancer samples: Results from the TMB2 harmonization project comparing three NGS panels","volume":"9","author":"Lora","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jmoldx.2022.01.008","article-title":"Evaluation of the TruSight Oncology 500 Assay for Routine Clinical Testing of Tumor Mutational Burden and Clinical Utility for Predicting Response to Pembrolizumab","volume":"24","author":"Wei","year":"2022","journal-title":"J. Mol. Diagn."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","article-title":"Gastric cancer, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Ajani","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ajco.13555","article-title":"CDK4\/6 inhibitor plus endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: The new standard of care","volume":"17","author":"Hui","year":"2021","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.7150\/jca.48944","article-title":"Comparative overall survival of CDK4\/6 inhibitors plus endocrine therapy vs. endocrine therapy alone for hormone receptor-positive, HER2-negative metastatic breast cancer","volume":"11","author":"Lin","year":"2020","journal-title":"J. Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhang, J., Tang, P.M., Zhou, Y., Cheng, A.S., Yu, J., Kang, W., and To, K.F. (2019). Targeting the oncogenic FGF-FGFR axis in gastric carcinogenesis. Cells, 8.","DOI":"10.3390\/cells8060637"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12967-021-02842-1","article-title":"Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer","volume":"19","author":"Mezynski","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Shimozaki, K., Shinozaki, E., Yamamoto, N., Imamura, Y., Osumi, H., Nakayama, I., Wakatsuki, T., Ooki, A., Takahari, D., and Ogura, M. (2022). KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer. J. Cancer Res. Clin. Oncol., 1\u201311.","DOI":"10.1007\/s00432-022-03966-7"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Wang, Z., Wang, X., Xu, Y., Li, J., Zhang, X., Peng, Z., Hu, Y., Zhao, X., Dong, K., and Zhang, B. (2022). Mutations of PI3K-AKT-mTOR pathway as predictors for immune cell infiltration and immunotherapy efficacy in dMMR\/MSI-H gastric adenocarcinoma. BMC Med., 20.","DOI":"10.1186\/s12916-022-02327-y"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cao, G.-d., Chen, K., Chen, B., and Xiong, M.-M. (2017). Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients. BMC cancer, 17.","DOI":"10.1186\/s12885-017-3851-y"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Cao, G.-D., Chen, K., Xiong, M.-M., and Chen, B. (2016). HER3, but not HER4, plays an essential role in the clinicopathology and prognosis of gastric cancer: A meta-analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161219"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e0299121","DOI":"10.1128\/mbio.02991-21","article-title":"Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models","volume":"13","author":"Queen","year":"2022","journal-title":"mBio"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.tranon.2019.03.003","article-title":"Fusobacterium nucleatum Contributes to the Carcinogenesis of Colorectal Cancer by Inducing Inflammation and Suppressing Host Immunity","volume":"12","author":"Wu","year":"2019","journal-title":"Transl. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1980347","DOI":"10.1080\/19490976.2021.1980347","article-title":"Fusobacterium nucleatum promotes colorectal cancer metastasis through miR-1322\/CCL20 axis and M2 polarization","volume":"13","author":"Xu","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","article-title":"Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer","volume":"6","author":"Gao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10120-022-01286-w","article-title":"A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer","volume":"25","author":"Hasegawa","year":"2022","journal-title":"Gastric Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Ryu, M.-H., Park, Y.S., Ma, J., Lee, S.Y., Kim, D., and Kang, Y.-K. (2022). Predictive biomarkers for the efficacy of nivolumab as \u2265 3rd-line therapy in patients with advanced gastric cancer: A subset analysis of ATTRACTION-2 phase III trial. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09488-2"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10120-021-01175-8","article-title":"Tumor mutation burden as a biomarker in resected gastric cancer via its association with immune infiltration and hypoxia","volume":"24","author":"Wang","year":"2021","journal-title":"Gastric Cancer"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41591-021-01406-6","article-title":"Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade","volume":"27","author":"Andrews","year":"2021","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40487-021-00171-3","article-title":"Response to PD-1-based immunotherapy for non-small cell lung cancer altered by gut microbiota","volume":"9","author":"He","year":"2021","journal-title":"Oncol. Ther."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13073-022-01037-7","article-title":"Interaction of bacterial genera associated with therapeutic response to immune checkpoint PD-1 blockade in a United States cohort","volume":"14","author":"Newsome","year":"2022","journal-title":"Genome Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/1\/269\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:48:53Z","timestamp":1760147333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/1\/269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,30]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["cancers15010269"],"URL":"https:\/\/doi.org\/10.3390\/cancers15010269","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,30]]}}}